Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E. (EGX:RMDA)

Market Cap	6.62B
Revenue (ttm)	2.77B
Net Income (ttm)	363.84M
Shares Out	1.50B
EPS (ttm)	0.24
PE Ratio	18.20
Forward PE	12.12
Dividend	0.07 (1.52%)
Ex-Dividend Date	n/a

Volume	6,412,039
Average Volume	9,905,395
Open	4.270
Previous Close	4.270
Day's Range	4.290 - 4.600
52-Week Range	1.850 - 4.670
Beta	0.23
RSI	58.58
Earnings Date	Apr 1, 2025

About EGX:RMDA

Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E., together with its subsidiaries, produces and sells a range of branded generic pharmaceuticals, food supplements, veterinary products, and nutraceuticals in Egypt. It manufactures, markets, sells, and stores pharmaceutical reagents for human and veterinary use, and diagnostic reagents for individuals, laboratories, and hospitals; importing pharmaceutical reagents and raw materials; and producing food supplements for human use. The company offers a portfolio o...

• Industry: Pharmaceutical Preparations
• Founded: 1986
• Country: Egypt
• Stock Exchange: Egyptian Stock Exchange
• Ticker Symbol: RMDA

Financial Performance

In 2024, EGX:RMDA's revenue was 2.77 billion, an increase of 44.03% compared to the previous year's 1.92 billion. Earnings were 363.84 million, an increase of 62.79%.